Navigation Links
Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia

risks relating to the continued safety and efficacy of Hematide in clinical development, the potential for once per month dosing, regulatory requirements and approvals, research and development efforts, industry and competitive environment, intellectual property rights and disputes and other matters that are described in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement in this press release.

Contact

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications


'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
2. Affymax Announces Results From Phase 2 Clinical Trial of Hematide for the Treatment of Anemia in Dialysis Patients
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine

Post Your Comments:
(Date:11/6/2009).... 6 With his proposed health care ...ghts on cutting name-brand prescription drug costs... the "Part D" coverage gap, universally known as t...ential cost-cutting and feel it,s a promising star...rful lobbyists want a revised program that complet...
(Date:11/6/2009)... N.C., Nov. 6 Chimerix, Inc., a bi... antiviral therapeutics to address life-threatenin...f the company,s lead antiviral compound, CMX001, t...al Health Security Initiative (GHSI). CMX001 is a...r the treatment of smallpox, as well as other seri...
(Date:11/6/2009)...wswire/ -- NexBio Inc., in collaboration with scie...ention (CDC), St. Louis University, and the Univer... of two articles in the peer-reviewed journal PLoS...S181 (Fludase ® ) may play a potentially impo... Pandemic Influenza A(H1N1) and drug-resistant inf...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 1Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 2Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 3Refurbished Medical Imaging Equipment Provider Receives Prestigious Industry Honor 57635 1Refurbished Medical Imaging Equipment Provider Receives Prestigious Industry Honor 57635 2Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 1Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 2Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 3
...08 Thermo Fisher,Scientific Inc. (NYSE: TMO ), t... it has received U.S. Food and Drug Administration...gned to screen for methicillin-resistant,Staphyloc...uperbug." With,the highest Positive Predictive Val...tra provides accurate results within 24 hours. The...
...m results from phase 2 trial of novel compound ...Conn., April 3, 2008 Rib-X Pharmaceuticals,Inc. (...pany focused on the,discovery and development of n...esistant infections, today announced that Albert C...esenting at the 10th Annual,Superbugs & Superdrugs...
Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference 2
(Date:11/7/2009)...HOUSTON, Nov. 7 Calling this a "de...n (AMA), the AMA President J. James Rohack, M.D., ...ians from all state and medical specialty societie...aking meeting, where health system reform will top.../cgi-bin/prnh/20081209/AMALOGO ) ,, "Over the...
(Date:11/7/2009)...WASHINGTON, Nov. 7 With..., antichoice extremists are holding the entire bil...ey are demanding that the bill go far beyond the s...ncorporated into the original bill. In an outrage...rly Saturday afternoon, antichoice Democrats are d...
(Date:11/7/2009)...WASHINGTON, Nov. 7 The ... of Representatives to vote for the Stupak-Ellswor... Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski...l law on abortion funding and conscience protectio...H.R. 3962)," they said. ,, The letter was signe...
(Date:11/7/2009)...GTON, Nov. 7 Americans United for Life Action end...tupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-S...al money from going to abortion in health care ref...nt and CEO Dr. Charmaine Yoest said, "Americans Un...Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith A...
(Date:11/7/2009)...should not assume that all youth will rebel, exper...s) -- Teens are more likely to behave badly if the...und. , "Parents who believe they are simply being ...illing prophecy," Christy Buchanan, a psychology p...f the study, said in a university news release. "N...
Breaking Medicine News(10 mins):Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...2007 Today, The National Institutes of Health is ...rs global theme issue on poverty and human develop...research by more than 230 journals worldwide. , ... Human Development in October. Twenty-five of Else...
... know what causes epileptic seizures, but research...e step closer to solving this puzzle with the help...leptic mouse. , This is the first human genetic m...and the genesis of epilepsy, which will aid in the...
... 22, 2007) -- Pall Corporation (NYSE: PLL) launche...s receive the safest possible platelet transfusion...e to collect donated blood. In addition to increas...imited donations without increasing hospital or bl...
...ng one of the biggest dangers for the future of th...amaging flora and fauna. With their vantage point ...ut effective global measurements of air-polluting ...ascati, Italy, last week to discuss the contributi...
...rence between upbeat, less positive patients , ... positive nor negative emotional states predict ho...udy finds. , University of Pennsylvania researcher... finding that emotional well-being would predict t...
...RNewswire-FirstCall/ -- China Medical,Technologies... China-based,medical device company that develops,...ostic products and high intensity focused ultrasou...007") and will provide a revised range of targeted...
Other Medicine News:Health News:Elsevier journals participate widely in global theme issue on poverty and human development 2Health News:Childhood epilepsy research offers new hope for seizure control 2Health News:Pall launches new products to increase supply of safe blood 2Health News:Pall launches new products to increase supply of safe blood 3Health News:Pall launches new products to increase supply of safe blood 4Health News:Space sensors shed new light on air quality 2Health News:Space sensors shed new light on air quality 3Health News:Emotional State Doesn't Affect Cancer Survival 2Health News:Emotional State Doesn't Affect Cancer Survival 3Health News:Emotional State Doesn't Affect Cancer Survival 4Health News:Emotional State Doesn't Affect Cancer Survival 5Health News:China Medical Technologies to Announce Financial Results for the Second Quarter Ended September 30, 2007 on November 20, 2007 2
ABX Pentra DF 120
PDM PD Meter
Optima III 45 Noninsulated Stabilizing Grasper, without ratchet
Optima III 45 Noninsulated Cobra Grasper, without ratchet
Medicine Products: